We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byMackenzie Jimenez
Modified over 2 years ago
© Mukoviszidose e.V. Patient registries: The role of patient organisations Dr. Andreas Reimann Mukoviszidose e.V. – German CF-association © Mukoviszidose e.V.
Patient registries: Why? Epidemiological information –Prevalence –Incidence Demographic information Genetics (if applicable) Information about way of diagnosis Localisation of care Health status of patients Treatment schemes Outcomes Epidemiological information –Prevalence –Incidence Demographic information Genetics (if applicable) Information about way of diagnosis Localisation of care Health status of patients Treatment schemes Outcomes Science Understanding natural courses of disease Estimating no. of undiagnosed patients Organizing care better Improving care Identifying unmet needs Science Understanding natural courses of disease Estimating no. of undiagnosed patients Organizing care better Improving care Identifying unmet needs © Mukoviszidose e.V.
Generic types of registries QM- supporting registry QM- driving registry Basic registry ? © Mukoviszidose e.V. Comprehensive Information Epidemiological information only Update per patient once per year Event-driven update per patient
Completeness Complete National Registry Incomplete National Registry Complete Regional Registry Incomplete Regional Registry © Mukoviszidose e.V. Nationwide Regional Almost all (diagnosed) patients Sub-group of patients
Scope of registries Comprehensive Registry Epidemiology DemographicsGeneticsLocation Care DiagnosisHealth-Status Treatment schemes Outcomes © Mukoviszidose e.V.
Ways of organizing registries Organizer:Public bodies Scientific networks Patient organizat- ions Single academics or institutions Finance Access +++(+)++- Organisation ++ ?+ Comprehensiveness ?++ Completeness +++??? Code of conduct +++ ?? © Mukoviszidose e.V.
Code of conduct Confidentiality Quality of data Clarification of data queries External evaluation Reporting –Entire data-set –Centre specific data Publication policy Access to (pseudo/anonymized) data © Mukoviszidose e.V.
Role of patient- organizations Motivating and informing patients Input to scope of registry Organizational support Providing data for scientific and health-care system related purposes Financial support Evaluating registry reports/drawing conclusions on health-care policies © Mukoviszidose e.V.
Concerns of patients Dont know what this is good for Confidentiality Feeling outside the loop Lacking or hampered access to (aggregated) data Poor quality of data © Mukoviszidose e.V.
EXAMPLE: GERMAN CF REGISTRY © Mukoviszidose e.V.
Quality-Management CF-Germany PatientregistryCentre-software muko.dokAnnual report/commissioned reportingQuality circlesBenchmarking In-house-education Hospitation-program Other programs © Mukoviszidose e.V.
German CF-patient registry Organized on behalf of Mukoviszidose e.V. by the centre for quality and management of the Lower-Saxony Chamber of Pyhsicians in Hannover Financed by Mukoviszidose e.V., partially co-financed by Christiane Herzog Foundation 95 CF-care centres Patients (including 684 dead patients) Patients have agreed to transfer pseudonomyised data New software: muko.dok Annual report Commissioned reports © Mukoviszidose e.V.
Organization of German CF-registry CF-centres Patient consent Pseudonomyzation Data entry Step I: annually Step II: event driven Provides medical/scientific input Data centre Hannover Data management Query management Evaluation Reporting Committee for Therapy and Quality of Mukoviszidose e.V. Access to aggregated data Defines code of conduct Governs publications including annual report Decides on commissioned reporting (commercial/scientific) Provides scientific and medical input Is appointed by and reports into Board Board of Mukoviszidose e.V. Governs entire program Decides on financial rewards for CF-centres Contractual management © Mukoviszidose e.V.
Beispiel: Altersentwicklung seit 1995 © Mukoviszidose e.V.
Benchmarking (= Lernen von den/dem Besten) Projekt Benchmarking Benchmarking: Dynamisierung des Qualitätsentwicklung (Konsentierung(gemeinsam) PDCA (Wirksamkeit)
COMMISSIONING IS CHANGING! Feedback on the Deanerys annual Commissioning Visit process over recent years has demonstrated that it provides a comprehensive,
Understanding Private Payers & Maximizing Private Payer Reimbursement Strategies: Understanding the Process Barbara Grenell, Preferred Health Strategies.
Powerpoint slides – NEC Manual A functional National Prevention of Blindness Committee (NPBC) National Prevention of Blindness Committee: A representative.
Sponsored by the National Association of Community Health Centers Presented By Shoreline Health Solutions, LLC Trudy Brown Ripin, MPHPresident & Founder.
Public Health Essential Service #2 Diagnose and Investigate Health Problems and Health Hazards in the Community.
NIHR Delivering Better Health 20 November 2012, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
Quality Improvement Program 28 TAC §10.22 Workers’ Compensation Health Care Networks.
A Model for Program Planning in Health Promotion PRECEDE - PROCEED.
WHO Strategy on Research for Health Rob Terry – Project Manager, RPC.
Investigator Responsibilities in Clinical Research Melissa Adde Director, Clinical Trials Office, INCTR
M&E for Accountability & Global Progress Tracking Monitoring, Operations Research and Evaluation Team UNAIDS/Geneva April 2007.
Understanding Our HRPP and Your Role in the Accreditation Process.
1 Large Research and Medical Databases Clinical Trial Registry and National Medical Database : Indian Initiatives Dr. Vijay Kumar Scientist F and Head,
Project funded by The European Union Government of the Republic of Serbia European Integration Office All presentations are available on the PPF5 website:
Measuring innovation South Asian Regional Workshop on Science, Technology and Innovation Statistics Kathmandu, Nepal 6-9 December 2010.
Evaluation of EHDI Programs National EHDI Coordinators Meeting Author and Presenter: Janet M. Farrell, Program Director MA Universal Newborn Hearing Screening.
Connecting Libraries to Organizational Mission: Using Assessment to Strengthen the Academic Health Sciences Librarys Institutional Role James Shedlock,
PDA is OK ….. Public/Private Doctor Agreement in Managing TB Cases Sandra Guerra-Cantu, MD, MPH Region 8 Medical Director.
Measuring innovation CENTRAL ASIAN SUB-REGIONAL CONSULTATION MEETING ON SCIENCE, TECHNOLOGY AND INNOVATION (STI) STATISTICS AND INDICATORS.
Local Authority public health data access - update Dr Robert Kyffin Data and Information Policy and Partnerships Lead Chief Knowledge Officer’s Directorate.
Building an EU consensus for minimum quality standards in the prevention, treatment and harm reduction of drugs Quality Standards - Policy Perspectives.
Commissioning Patient Centered Care & Improving Outcomes for People with Cancer Di Riley Associate Director, Clinical Outcomes NCIN.
Focusing on Student Learning Developing Assessment Systems for Student and Program Development May 24, 2006 Forsyth Tech Community College.
Every Womans Life PROGRAM MANUAL UPDATE
Essential Service #6 :. Refresher: Why learn about Essential Services? Improve quality and performance. Achieve better outcomes – improved health, less.
Keeping Children Safe Developing a Local Strategic Quality Assurance Framework David Worlock November 2010.
Health Systems and Actors Tom Merrick, World Bank.
NIGB NATIONAL INFORMATION GOVERNANCE BOARD Harry Cayton, Chair, National Information Governance Board.
Developing Quality Management Activities from the Ground Up Elizabeth Graves Love, MPH Houston EMA.
Assessing Community Health: Measures of Community Health Status and Sources of Population-Based Health Data Don Cibula, PhD Assistant Professor, Department.
© 2016 SlidePlayer.com Inc. All rights reserved.